Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
about
ADAMTS-12 associates with and degrades cartilage oligomeric matrix proteinA systems biology approach to synovial joint lubrication in health, injury, and diseaseArticular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilageBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Soluble biomarkers development in osteoarthritis: from discovery to personalized medicineSkeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagenAntioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasiaIncreased concentrations of bone sialoprotein in joint fluid after knee injury.Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial.Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammationTrabecular bone loss at a distant skeletal site following noninvasive knee injury in miceDetermination of the Interday and Intraday Reliability of Serum Cartilage Oligomeric Matrix Protein in a Physically Active PopulationSoft tissue knee injury with concomitant osteochondral fracture is associated with higher degree of acute joint inflammation.Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?Return to play guidelines after anterior cruciate ligament surgerySerum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.Serum Cartilage Oligomeric Matrix Protein Levels in Collegiate Soccer Athletes over the Duration of an Athletic Season: A Pilot Study.High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.Inflammatory biomarkers in osteoarthritis.Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritisLongitudinal documentation of serum cartilage oligomeric matrix protein and patient-reported outcomes in collegiate soccer athletes over the course of an athletic seasonSerum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women.Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.Elucidating the Molecular Composition of Cartilage by Proteomics.Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repairThe complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis.Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Proteomic profiling and functional characterization of early and late shoulder osteoarthritis.New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options.Intra-articular hyaluronic acid: potential treatment of younger patients with knee injury and/or post-traumatic arthritis.Current serological possibilities for the diagnosis of arthritis with special focus on proteins and proteoglycans from the extracellular matrix.The role of complement inhibitors beyond controlling inflammation.Meniscal biology in health and disease.Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury.
P2860
Q24317122-ECCBE214-9343-4942-A02C-EEFF96A89F2BQ24608533-896AA540-883F-4B24-9F22-F16C7DE33C19Q24805835-A49F1168-2BE3-4AE7-9203-4283205F75FDQ27687777-574D9EB3-822B-4E72-8D35-7958472A3702Q28077398-EB4E58FE-1B7C-44D3-8985-C040F4A1FBD5Q28508457-1F71BF31-DF55-40E9-BEBF-2FD66D0631BDQ28648075-8C01448B-59D6-4BDF-9B99-1BE8D7559A1DQ33579218-24A45672-E571-4D07-A770-2074D037F99DQ34152911-B9F70139-C2FD-4444-9609-3540F6524D91Q34283578-27B2591B-C67C-47E9-A509-AB6A00B755C8Q34614103-3D186C69-D6CD-4BED-9A54-F7120BBD970EQ34804429-42E583F2-27EC-4A4F-82C7-D14A36AA2166Q34975034-588B2279-A4DC-43E8-9969-AC69CF650E65Q34978075-56C03FEB-DFC9-4C37-BA1F-906E09E73642Q35130236-3A3C8069-2060-4EAE-B826-09601AFF966DQ35146138-432EE516-248E-413C-B8E0-7B90408C6DE0Q35332348-E5D88E8C-CE83-4F90-A6C3-81B912AF11BDQ35548142-1BE746F8-D40F-495A-9009-D8E30C1B6D3EQ35555490-B50914EC-2F3F-469C-B23F-C9C82F472E4AQ35570417-64DE9E1E-04A2-453E-B2EC-BADE24EC6232Q35712297-16F7554E-8C2D-4EAC-9B6B-F81D6BD92DC5Q35869021-5F5FE8E3-79C3-4B87-B447-7B1137400DD9Q36074512-844E64A7-D103-46F0-8E9C-DCF01CAE115BQ36242268-3C847037-D1FA-44F9-97ED-18A2CA3A5C46Q36294719-E0287621-7AE8-4FD7-BF87-7E837654E550Q36738029-78279B5E-D494-4318-A991-47823BEED05DQ36761786-6CC33F27-29BD-4F87-B904-B7BF5A711BA0Q36954971-55ED0544-C38E-449B-B6C4-FBEA055DF857Q37029148-2235BF65-7E54-40A5-AD6B-9C35BCEB0A7FQ37258065-891264A4-D84B-46B3-8760-562F2662A279Q37315643-68958A5C-EE2A-45AB-ADC6-9593613C0CD4Q37457066-65E56BFB-C961-43E8-9240-C47F32E01695Q37462448-830F205F-EEDF-46E1-8640-F2E63169B1F8Q37691017-661241F2-9FF3-4FEF-BDB4-D705A629D3FEQ37770129-0BF74095-5B49-4C88-9226-CC10C218F403Q37889573-B2C0E317-548C-4078-93F6-0B6D002F84C6Q38266373-416C774B-3EAD-466E-A0D3-36080BFCFF7CQ39201843-D8DE0066-BF16-44F3-8FA9-570DF28B9684Q39313209-9C04DFD8-BD2C-44E1-A2D0-6A0ED4937457Q39528198-EB5AEC18-EE68-4031-B31F-150E4197F068
P2860
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@ast
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@en
Release of cartilage oligomeric matrix protein
@nl
type
label
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@ast
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@en
Release of cartilage oligomeric matrix protein
@nl
prefLabel
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@ast
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@en
Release of cartilage oligomeric matrix protein
@nl
P2093
P2860
P356
P1476
Release of cartilage oligomeri ...... e injury and in osteoarthritis
@en
P2093
Heinegård DK
Lohmander LS
P2860
P356
10.1136/ARD.53.1.8
P407
P577
1994-01-01T00:00:00Z